The first-of-its-kind, configurable platform enables BioPharma organizations to streamline expanded access management by seamlessly navigating complex regulatory requirements, generating real-world…
ST. LOUIS, May 28, 2025 /PRNewswire/ -- Panome Bio, a leading provider of multi-omic services, has added transcriptional profiling to…
CARY, N.C., May 28, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical…
Collaboration Leverages the Foundation's IBD Plexus® Research Accelerator with PhaseV's AI/ML Solutions to Overcome Key Challenges in Clinical Development and Enhance…
NEW CANAAN, Conn., May 28, 2025 /PRNewswire/ -- FlyteHealth, a leading virtual cardiometabolic care provider, announced year-one outcomes from its Comprehensive…
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a…
The company has developed the first-ever platform to unlock precision control over glycans, essential sugar molecules found on the surface…
Trial is evaluating VIPER-101, a novel, gene edited, autologous dual-population CAR-T therapy in patients with T-cell lymphomaPHILADELPHIA, May 28, 2025…
Experienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood…
Coverage marks SeaStar Medical’s second award by CMS for reimbursement of medical expenses for Medicare and Medicaid patients in a…